SenesTech, Inc. (SNES)
NASDAQ: SNES · Real-Time Price · USD
2.516
-0.124 (-4.69%)
At close: Nov 15, 2024, 4:00 PM
2.220
-0.296 (-11.78%)
After-hours: Nov 15, 2024, 4:41 PM EST
Company Description
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control.
It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
SenesTech, Inc.
| Country | United States |
| Founded | 2004 |
| IPO Date | Dec 8, 2016 |
| Industry | Specialty Chemicals |
| Sector | Materials |
| Employees | 25 |
| CEO | Joel Fruendt |
Contact Details
Address: 23460 North 19th Avenue, Suite 110 Phoenix, Arizona 85027 United States | |
| Phone | 928 779 4143 |
| Website | senestech.com |
Stock Details
| Ticker Symbol | SNES |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001680378 |
| CUSIP Number | 81720R208 |
| ISIN Number | US81720R5054 |
| Employer ID | 20-2079805 |
| SIC Code | 2870 |
Key Executives
| Name | Position |
|---|---|
| Joel L. Fruendt | Chief Executive Officer, President and Director |
| Thomas C. Chesterman M.B.A. | Executive Vice President, Chief Financial Officer, Treasurer and Secretary |
| Robert Blum | Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Nov 12, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 12, 2024 | 8-K | Current Report |
| Oct 4, 2024 | EFFECT | Notice of Effectiveness |
| Oct 4, 2024 | 424B3 | Prospectus |
| Sep 27, 2024 | UPLOAD | Filing |
| Sep 23, 2024 | S-3 | Registration statement under Securities Act of 1933 |
| Aug 30, 2024 | D | Notice of Exempt Offering of Securities |